Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCommerce Bank
Latest Disclosed Ownership32,030 shares
Latest Disclosed Value $ 4,892,582
Commerce Bank reports 41.70% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 11, 2026 - Commerce Bank filed a 13F-HR form disclosing ownership of 32,030 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $4,892,582 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 22,604 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 41.70% during the quarter. The current value of the position is $4,601,430 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 32,030 9,426 41.70 4,893 57.00 0.0101
2026-02-13 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 22,604 461 2.08 3,116 9.76 0.0172
2025-11-12 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 22,143 358 1.64 2,840 7.70 0.0158
2025-08-07 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 21,785 -2,028 -8.52 2,636 -0.68 0.0156
2025-05-08 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 23,813 2,581 12.16 2,655 28.46 0.0169
2025-02-13 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 21,232 -405 -1.87 2,066 -16.96 0.0127
2024-11-08 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 21,637 82 0.38 2,489 8.46 0.0152
2024-08-12 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 21,555 -157 -0.72 2,295 9.24 0.0149
2024-05-03 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 21,712 -614 -2.75 2,100 -6.83 0.0139
2024-02-09 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 22,326 -6 -0.03 2,254 -0.88 0.0160
2023-11-14 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 22,332 307 1.39 2,275 2.34 0.0179
2023-08-08 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 22,025 -453 -2.02 2,223 7.50 0.0166
2023-05-04 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 22,478 34 0.15 2,068 1.52 0.0162
2023-02-10 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 22,444 -1,060 -4.51 2,036 14.00 0.0165
2022-11-04 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 23,504 1,050 4.68 1,786 -5.90 0.0155
2022-08-12 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 22,454 210 0.94 1,898 -2.77 0.0155
2022-05-09 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 22,244 -629 -2.75 1,952 -2.45 0.0134
2022-02-14 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 22,873 -1,883 -7.61 2,001 -1.19 0.0131
2021-11-09 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 24,756 -1,189 -4.58 2,025 -14.45 0.0143
2021-08-09 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 25,945 95 0.37 2,367 7.10 0.0168
2021-05-05 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 25,850 856 3.42 2,210 -6.36 0.0168
2021-02-09 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 24,994 -109 -0.43 2,360 8.11 0.0191
2020-11-06 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 25,103 -10,088 -28.67 2,183 -28.99 0.0197
2020-08-07 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 35,191 11,514 48.63 3,074 57.48 0.0300
2020-05-08 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 23,677 -218 -0.91 1,952 -13.74 0.0236
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 23,895 -1,656 -6.48 2,263 1.89 0.0216
2019-11-12 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 25,551 -968 -3.65 2,221 -8.26 0.0228
2019-08-07 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 26,519 -94 -0.35 2,421 -5.39 0.0272
2019-05-08 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 26,613 623 2.40 2,559 14.70 0.0303
2019-02-11 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 25,990 -587 -2.21 2,231 -2.58 0.0284
2018-11-02 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 26,577 -1,692 -5.99 2,290 7.21 0.0273
2018-08-08 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 28,269 -328 -1.15 2,136 -7.61 0.0271
2018-05-03 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 28,597 593 2.12 2,312 -1.70 0.0305
2018-02-12 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 28,004 664 2.43 2,352 0.21 0.0306
2017-11-07 2017-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 27,340 -1,239 -4.34 2,347 -1.59 0.0319
2017-11-07 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 28,579 2,385
2017-08-08 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 28,579 -2,824 -8.99 2,385 2.23 0.0334
2017-05-05 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 31,403 -2,785 -8.15 2,333 -6.31 0.0333
2017-02-08 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 34,188 -3,725 -9.83 2,490 -16.83 0.0372
2016-11-03 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 37,913 -1,167 -2.99 2,994 -7.13 0.0466
2016-08-09 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 39,080 -766 -1.92 3,224 11.71 0.0510
2016-04-27 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 39,846 3,927 10.93 2,886 -6.60 0.0479
2016-02-12 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 35,919 337 0.95 3,090 -5.53 0.0517
2015-11-10 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 35,582 -1,532 -4.13 3,271 -10.38 0.0563
2015-08-03 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 37,114 -2,413 -6.10 3,650 -6.36 0.0572
2015-05-06 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 39,527 2,628 7.12 3,898 14.01 0.0606
2015-02-11 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 36,899 -1,974 -5.08 3,419 -6.56 0.0540
2014-11-06 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 38,873 592 1.55 3,659 5.60 0.0604
2014-08-05 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 38,281 464 1.23 3,465 7.78 0.0566
2014-05-09 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 37,817 1,828 5.08 3,215 11.13 0.0547
2014-02-14 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 35,989 2,290 6.80 2,893 11.91 0.0501
2013-11-05 2013-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 29,340 -6,022 2,211 0.0399
2013-11-05 2013-09-30 13F/A-2 NOVARTIS A G SPONSORED ADR 66987V109 33,699 -1,663 -4.70 2,585 3.40 0.0466
2013-11-04 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 29,340 2,211
2013-08-07 2013-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 35,362 4,532 14.70 2,500 13.84 0.0465
2013-08-08 2013-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 30,830 30,830 2,196 0.0428
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.